IMVT

insider transactions

Immunovant, Inc. — buys & sells by directors, officers and 10% owners (SEC Form 4).

30D 90D 1Y

Net shares · 365d

-311.1K

0 buy · 311.1K sell

Net value · 365d

-$9.9M

$0 in · $9.9M out

Sentiment · 365d

Net selling

0% buying · 100% selling

Open-market trades · 365d

0 buy · 311.1K sell

Net buy / sell volume

Tap or hover the chart for daily net volume. Green = net buying, red = net selling.

All transactions

Exercise·M
Jun 15, 26

Atul Pande

Director · 10b5-1

$0

1.5K sh

Own +2%
Sell·S
Jun 15, 26

Atul Pande

Director · 10b5-1

$51.0K

1.5K sh · $34.02

Own -1%
Exercise·M
Jun 15, 26

Atul Pande

Director · 10b5-1

$12.6K

1.5K sh · $8.43

Own +1%
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$0

16.3K sh

Own New
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$0

77.2K sh

Own New
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$0

71.5K sh

Own New
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$0

31.7K sh

Own New
Sell·S
May 28, 26

Andrew J. Fromkin

Director

$7.1M

210.5K sh · $33.56

Own -74%
Sell·S
May 28, 26

Andrew J. Fromkin

Director

$374.8K

11.5K sh · $32.64

Own -4%
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$239.0K

16.3K sh · $14.70

Own +6%
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$650.6K

77.2K sh · $8.43

Own +38%
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$567.6K

71.5K sh · $7.94

Own +54%
Exercise·M
May 28, 26

Andrew J. Fromkin

Director

$158.0K

31.7K sh · $4.99

Own +32%
Exercise·M
May 20, 26

Atul Pande

Director · 10b5-1

$0

6.0K sh

Own +2%
Sell·S
May 20, 26

Atul Pande

Director · 10b5-1

$192.0K

6.0K sh · $32.00

Own -5%
Exercise·M
May 20, 26

Atul Pande

Director · 10b5-1

$50.6K

6.0K sh · $8.43

Own +5%
Sell·S
May 20, 26

Melanie Gloria

Chief Operating Officer

$55.9K

1.7K sh · $32.95

Own -1%
Sell·S
May 20, 26

Melanie Gloria

Chief Operating Officer

$37.6K

1.2K sh · $32.15

Own -0%
Sell·S
May 20, 26

Melanie Gloria

Chief Operating Officer

$7.6K

249 sh · $30.41

Own -0%
Sell·S
May 1, 26

Robert Graham Susman

Director · 10b5-1

$68.0K

2.5K sh · $27.17

Own -6%
Sell·S
Apr 23, 26

Jay S Stout

Chief Technology Officer

$81.6K

2.8K sh · $29.62

Own -1%
Sell·S
Apr 23, 26

Tiago Girao KEY

Chief Financial Officer

$763.0K

25.8K sh · $29.62

Own -9%
Sell·S
Apr 8, 26

Christopher Van Tuyl

Chief Legal Officer

$128.2K

5.2K sh · $24.83

Own -3%
Sell·S
Apr 8, 26

Jay S Stout

Chief Technology Officer

$37.7K

1.5K sh · $24.83

Own -1%
Sell·S
Apr 8, 26

Jay S Stout

Chief Technology Officer

$213.9K

8.6K sh · $24.83

Own -3%
Sell·S
Apr 8, 26

Melanie Gloria

Chief Operating Officer

$216.6K

8.7K sh · $24.83

Own -3%
Grant·A
Apr 7, 26

Frank Torti

Director

$0

88.3K sh

Own New
Grant·A
Apr 7, 26

Frank Torti

Director

$0

174.2K sh

Own +21%
Grant·A
Apr 7, 26

Atul Pande

Director

$0

7.1K sh

Own New
Grant·A
Apr 7, 26

Atul Pande

Director

$0

13.9K sh

Own +13%
Grant·A
Apr 7, 26

Robert Graham Susman

Director

$0

7.1K sh

Own New
Grant·A
Apr 7, 26

Robert Graham Susman

Director

$0

13.9K sh

Own +55%
Grant·A
Apr 7, 26

Jay S Stout

Chief Technology Officer

$0

96.9K sh

Own New
Grant·A
Apr 7, 26

Jay S Stout

Chief Technology Officer

$0

66.9K sh

Own +34%
Grant·A
Apr 7, 26

Christopher Van Tuyl

Chief Legal Officer

$0

59.8K sh

Own New
Grant·A
Apr 7, 26

Christopher Van Tuyl

Chief Legal Officer

$0

41.3K sh

Own +28%
Grant·A
Apr 7, 26

Eric Venker KEY

Chief Executive Officer

$0

336.0K sh

Own New
Grant·A
Apr 7, 26

Eric Venker KEY

Chief Executive Officer

$0

232.3K sh

Own +1187%
Grant·A
Apr 7, 26

Douglas J. Hughes

Director

$0

7.1K sh

Own New
Grant·A
Apr 7, 26

Douglas J. Hughes

Director

$0

13.9K sh

Own +11%
Grant·A
Apr 7, 26

Melanie Gloria

Chief Operating Officer

$0

121.1K sh

Own New
Grant·A
Apr 7, 26

Melanie Gloria

Chief Operating Officer

$0

83.7K sh

Own +49%
Grant·A
Apr 7, 26

Tiago Girao KEY

Chief Financial Officer

$0

94.0K sh

Own New
Grant·A
Apr 7, 26

Tiago Girao KEY

Chief Financial Officer

$0

65.0K sh

Own +31%
Grant·A
Apr 7, 26

Andrew J. Fromkin

Director

$0

7.1K sh

Own New
Grant·A
Apr 7, 26

Andrew J. Fromkin

Director

$0

13.9K sh

Own +16%
Sell·S
Apr 2, 26

Eric Venker KEY

Chief Executive Officer

$34.7K

1.4K sh · $24.60

Own -7%
Sell·S
Apr 2, 26

Eric Venker KEY

Chief Executive Officer

$308.2K

12.8K sh · $24.04

Own -38%
Exercise·M
Apr 1, 26

Eric Venker KEY

Chief Executive Officer

$0

368.8K sh

Own +50%
Other·D
Apr 1, 26

Eric Venker KEY

Chief Executive Officer

$8.4M

335.0K sh · $25.10

Own -91%
Exercise·M
Apr 1, 26

Eric Venker KEY

Chief Executive Officer

$5.3M

368.8K sh · $14.46

Own New
Sell·S
Mar 18, 26

Christopher Van Tuyl

Chief Legal Officer

$71.8K

2.9K sh · $24.97

Own -2%
Sell·S
Feb 25, 26

Melanie Gloria

Chief Operating Officer

$27.2K

942 sh · $28.90

Own -1%
Sell·S
Feb 25, 26

Melanie Gloria

Chief Operating Officer

$24.2K

859 sh · $28.16

Own -0%
Sell·S
Feb 25, 26

Melanie Gloria

Chief Operating Officer

$38.8K

1.4K sh · $26.98

Own -1%
Sell·S
Jan 21, 26

Jay S Stout

Chief Technology Officer

$51.5K

2.0K sh · $26.03

Own -1%
Sell·S
Jan 7, 26

Jay S Stout

Chief Technology Officer

$1.5K

55 sh · $26.92

Own -0%
Sell·S
Jan 7, 26

Jay S Stout

Chief Technology Officer

$30.4K

1.1K sh · $26.51

Own -1%

Date▾	Insider	Role	Type	Shares	Own Δ	Price	Value
Jun 15, 2026	Atul Pande 10b5-1	Director	Exercise M	1.5K	+2%	—	$0
Jun 15, 2026	Atul Pande 10b5-1	Director	Sell S	1.5K	-1%	$34.02	$51.0K
Jun 15, 2026	Atul Pande 10b5-1	Director	Exercise M	1.5K	+1%	$8.43	$12.6K
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	16.3K	New	—	$0
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	77.2K	New	—	$0
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	71.5K	New	—	$0
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	31.7K	New	—	$0
May 28, 2026	Andrew J. Fromkin	Director	Sell S	210.5K	-74%	$33.56	$7.1M
May 28, 2026	Andrew J. Fromkin	Director	Sell S	11.5K	-4%	$32.64	$374.8K
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	16.3K	+6%	$14.70	$239.0K
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	77.2K	+38%	$8.43	$650.6K
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	71.5K	+54%	$7.94	$567.6K
May 28, 2026	Andrew J. Fromkin	Director	Exercise M	31.7K	+32%	$4.99	$158.0K
May 20, 2026	Atul Pande 10b5-1	Director	Exercise M	6.0K	+2%	—	$0
May 20, 2026	Atul Pande 10b5-1	Director	Sell S	6.0K	-5%	$32.00	$192.0K
May 20, 2026	Atul Pande 10b5-1	Director	Exercise M	6.0K	+5%	$8.43	$50.6K
May 20, 2026	Melanie Gloria	Chief Operating Officer	Sell S	1.7K	-1%	$32.95	$55.9K
May 20, 2026	Melanie Gloria	Chief Operating Officer	Sell S	1.2K	-0%	$32.15	$37.6K
May 20, 2026	Melanie Gloria	Chief Operating Officer	Sell S	249	-0%	$30.41	$7.6K
May 1, 2026	Robert Graham Susman 10b5-1	Director	Sell S	2.5K	-6%	$27.17	$68.0K
Apr 23, 2026	Jay S Stout	Chief Technology Officer	Sell S	2.8K	-1%	$29.62	$81.6K
Apr 23, 2026	Tiago Girao KEY	Chief Financial Officer	Sell S	25.8K	-9%	$29.62	$763.0K
Apr 8, 2026	Christopher Van Tuyl	Chief Legal Officer	Sell S	5.2K	-3%	$24.83	$128.2K
Apr 8, 2026	Jay S Stout	Chief Technology Officer	Sell S	1.5K	-1%	$24.83	$37.7K
Apr 8, 2026	Jay S Stout	Chief Technology Officer	Sell S	8.6K	-3%	$24.83	$213.9K
Apr 8, 2026	Melanie Gloria	Chief Operating Officer	Sell S	8.7K	-3%	$24.83	$216.6K
Apr 7, 2026	Frank Torti	Director	Grant A	88.3K	New	—	$0
Apr 7, 2026	Frank Torti	Director	Grant A	174.2K	+21%	—	$0
Apr 7, 2026	Atul Pande	Director	Grant A	7.1K	New	—	$0
Apr 7, 2026	Atul Pande	Director	Grant A	13.9K	+13%	—	$0
Apr 7, 2026	Robert Graham Susman	Director	Grant A	7.1K	New	—	$0
Apr 7, 2026	Robert Graham Susman	Director	Grant A	13.9K	+55%	—	$0
Apr 7, 2026	Jay S Stout	Chief Technology Officer	Grant A	96.9K	New	—	$0
Apr 7, 2026	Jay S Stout	Chief Technology Officer	Grant A	66.9K	+34%	—	$0
Apr 7, 2026	Christopher Van Tuyl	Chief Legal Officer	Grant A	59.8K	New	—	$0
Apr 7, 2026	Christopher Van Tuyl	Chief Legal Officer	Grant A	41.3K	+28%	—	$0
Apr 7, 2026	Eric Venker KEY	Chief Executive Officer	Grant A	336.0K	New	—	$0
Apr 7, 2026	Eric Venker KEY	Chief Executive Officer	Grant A	232.3K	+1187%	—	$0
Apr 7, 2026	Douglas J. Hughes	Director	Grant A	7.1K	New	—	$0
Apr 7, 2026	Douglas J. Hughes	Director	Grant A	13.9K	+11%	—	$0
Apr 7, 2026	Melanie Gloria	Chief Operating Officer	Grant A	121.1K	New	—	$0
Apr 7, 2026	Melanie Gloria	Chief Operating Officer	Grant A	83.7K	+49%	—	$0
Apr 7, 2026	Tiago Girao KEY	Chief Financial Officer	Grant A	94.0K	New	—	$0
Apr 7, 2026	Tiago Girao KEY	Chief Financial Officer	Grant A	65.0K	+31%	—	$0
Apr 7, 2026	Andrew J. Fromkin	Director	Grant A	7.1K	New	—	$0
Apr 7, 2026	Andrew J. Fromkin	Director	Grant A	13.9K	+16%	—	$0
Apr 2, 2026	Eric Venker KEY	Chief Executive Officer	Sell S	1.4K	-7%	$24.60	$34.7K
Apr 2, 2026	Eric Venker KEY	Chief Executive Officer	Sell S	12.8K	-38%	$24.04	$308.2K
Apr 1, 2026	Eric Venker KEY	Chief Executive Officer	Exercise M	368.8K	+50%	—	$0
Apr 1, 2026	Eric Venker KEY	Chief Executive Officer	Other D	335.0K	-91%	$25.10	$8.4M
Apr 1, 2026	Eric Venker KEY	Chief Executive Officer	Exercise M	368.8K	New	$14.46	$5.3M
Mar 18, 2026	Christopher Van Tuyl	Chief Legal Officer	Sell S	2.9K	-2%	$24.97	$71.8K
Feb 25, 2026	Melanie Gloria	Chief Operating Officer	Sell S	942	-1%	$28.90	$27.2K
Feb 25, 2026	Melanie Gloria	Chief Operating Officer	Sell S	859	-0%	$28.16	$24.2K
Feb 25, 2026	Melanie Gloria	Chief Operating Officer	Sell S	1.4K	-1%	$26.98	$38.8K
Jan 21, 2026	Jay S Stout	Chief Technology Officer	Sell S	2.0K	-1%	$26.03	$51.5K
Jan 7, 2026	Jay S Stout	Chief Technology Officer	Sell S	55	-0%	$26.92	$1.5K
Jan 7, 2026	Jay S Stout	Chief Technology Officer	Sell S	1.1K	-1%	$26.51	$30.4K

About IMVT insider trading

This page tracks insider transactions for Immunovant, Inc. (IMVT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.